FDA grants traditional approval for Calquence with bendamustine and Rituxan for untreated MCL patients ineligible for autologous HSCT.
Alex Biese is a Features Reporter at the USA TODAY NETWORK New Jersey and the Asbury Park Press. He covers a diverse range of topics, including medicine and healthcare, arts and entertainment, and social issues, with a particular focus on New Jersey and LGBTQ themes. Biese's work has been featured in prominent outlets such as USA TODAY, Yahoo News, and the Chicago Sun-Times, among others.